14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALINT.PA
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

IntegraGen SA stock price ended at 0.570€ on Tuesday, after losing 1.72%.
(Updated on Jun 25, 2024)

Sell candidate since May 31, 2024 Loss -10.94% PDF

The IntegraGen SA stock price fell by -1.72% on the last day (Tuesday, 25th Jun 2024) from 0.580€ to 0.570€. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.75% from a day low at 0.570€ to a day high of 0.580€. The price has fallen in 5 of the last 10 days and is down by -3.39% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 181 shares were bought and sold for approximately 103.17€ .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.23% during the next 3 months and, with a 90% probability hold a price between 0.457€ and 0.596€ at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALINT.PA Signals & Forecast

There are mixed signals in the stock today. The IntegraGen SA stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 0.591€ and 0.641€. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Tuesday, June 18, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for IntegraGen SA stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved 0.0100€ between high and low, or 1.75%. For the last week the stock has had daily average volatility of 6.75%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALINT.PA) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect IntegraGen SA to open at 0.573€, and during the day (based on 14 day Average True Range), to move between 0.536€ and 0.604€, which gives a possible trading interval of +/-0.0345€ (+/-6.05%) up or down from last closing price. If IntegraGen SA takes out the full calculated possible swing range there will be an estimated 12.09% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ 0.600€, some 0.0300€ (5.26%) from the current price of 0.570€, our system finds the risk reward not very attractive.

Is IntegraGen SA stock A Buy?

IntegraGen SA holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.046 Sell Candidate Unchanged

Predicted Opening Price for IntegraGen SA of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
0.573€ ( 0.585%) 0.570€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALINT.PA

Fibonacci Support & Resistance Levels

Level Price
R3 0.583 2.34%
R2 0.580 1.67%
R1 0.577 1.25%
Price 0.570
S1 0.570 -0.0854%
S2 0.567 -0.499%
S3 0.563 -1.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.700 22.81%
R2 0.640 12.28%
R1 0.600 5.26%
Price 0.570
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for IntegraGen SA Stock and on which exchange is it traded?
The symbol for IntegraGen SA is ALINT.PA and it is traded on the PAR (Euronext Paris).

Should I buy or sell IntegraGen SA Stock?
IntegraGen SA holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy IntegraGen SA Stock?
IntegraGen SA Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy IntegraGen SA Stock.

What's the current price of IntegraGen SA Stock?
As of the end of day on the Jun 25, 2024, the price of an IntegraGen SA (ALINT.PA) share was 0.570€.

What is the 52-week high and low for IntegraGen SA Stock?
The 52-week high for IntegraGen SA Stock is 1.57€ and the 52-week low is 0.545€.

What is the market capitalization of IntegraGen SA Stock?
As of the Jun 25, 2024, the market capitalization of IntegraGen SA is 3.836M.

When is the next earnings date for IntegraGen SA?
The upcoming earnings date for IntegraGen SA is Oct 15, 2024.
Click to get the best stock tips daily for free!

About IntegraGen SA

IntegraGen SA IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and hi... ALINT.PA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT